Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Karyopharm Therapeutics Inc. - Common Stock (NQ: KPTI ) 0.7010 +0.1010 (+16.83%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Karyopharm Therapeutics Inc. - Common Stock < Previous 1 2 3 4 5 6 Next > Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket December 16, 2024 Via Benzinga Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript November 05, 2024 KPTI earnings call for the period ending September 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Monday's After-Market Session September 30, 2024 Via Benzinga Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript August 06, 2024 KPTI earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Karyopharm Therapeutics's Earnings: A Preview February 28, 2024 Via Benzinga Earnings Preview For Karyopharm Therapeutics November 01, 2023 Via Benzinga 6 Analysts Have This to Say About Karyopharm Therapeutics August 03, 2023 Via Benzinga KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom May 23, 2024 These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress. Via InvestorPlace Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript May 08, 2024 KPTI earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 KPTI earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial 7 Biotech Penny Stocks on the Verge of Clinical Trial Victory February 25, 2024 Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session February 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 31, 2024 Via Benzinga Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript November 02, 2023 KPTI earnings call for the period ending September 30, 2023. Via The Motley Fool Topics Earnings Exposures Financial Stocks That Hit 52-Week Lows On Wednesday August 30, 2023 On Wednesday, 59 companies achieved new lows for the year. Via Benzinga Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript August 02, 2023 KPTI earnings call for the period ending June 30, 2023. Via The Motley Fool Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation July 26, 2023 Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced the presentation of updated exploratory subgroup analyses from the SIENDO study in patients with advanced or recurrent TP53 wild-type endometrial... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 18, 2023 During Tuesday's trading, 46 companies set new 52-week lows. Via Benzinga CMG Stock Alert: Chipotle Announces International Expansion Plan July 18, 2023 Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion. Via InvestorPlace Why Are Karyopharm Therapeutics Shares Gaining Today? July 18, 2023 Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares are trading higher after the FDA granted Fast Track Designation to the development program of selinexor for myelofibrosis, including primary... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 18, 2023 Via Benzinga Why Is CEL-SCI (CVM) Stock Down 23% Today? July 18, 2023 CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. Via InvestorPlace Why Is Masimo (MASI) Stock Down 30% Today? July 18, 2023 Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023. Via InvestorPlace Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket July 18, 2023 Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... Via Benzinga Why Is Karyopharm Therapeutics (KPTI) Stock Up 21% Today? July 18, 2023 Karyopharm Therapeutics (KPTI) stock is climbing higher on Tuesday after getting fast-track designation for its myelofibrosis treatment. Via InvestorPlace < Previous 1 2 3 4 5 6 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
